Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ResMed Inc. (RMD) had Revenue of $1.43B for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$1.43B
Net Income	$398.73M
Cost of Goods Sold	$540.43M
Gross Profit	$890.98M
Operating Expenses	$931.60M
Operating Income	$499.81M
Non-Operating Income/Expense	$2.50M
Pre-Tax Income	$502.31M
Normalized Pre-Tax Income	$502.31M
Income after Taxes	$398.73M
Income from Continuous Operations	$398.73M
Consolidated Net Income/Loss	$398.73M
Normalized Income after Taxes	$398.73M
EBIT	$499.81M
EBITDA	$568.84M
Weighted-Average Shares Outstanding (Basic)	145.34M
Weighted-Average Shares Outstanding (Diluted)	145.72M
Earnings per Share (EPS) (Basic)	$2.74
Earnings per Share (EPS) (Diluted)	$2.74
Balance Sheet Financials
Current Assets	$4.06B
Property, Plant, and Equipment	$566.97M
Long-Term Assets	$4.72B
Total Assets	$8.78B
Current Liabilities	$1.35B
Long-Term Debt	$404.17M
Long-Term Liabilities	$941.16M
Total Liabilities	$2.29B
Common Equity	$6.49B
Tangible Shareholders Equity	$3.02B
Shareholders Equity	$6.49B
Common Shares Outstanding	145.04M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.35B
Cash Flow from Investing Activities	$-161.55M
Cash Flow from Financial Activities	$-743.87M
Beginning Cash	$1.21B
End Cash	$1.66B
Increase/Decrease in Cash	$451.06M
Stock-Based Compensation	$76.89M
Common Stock Dividends Paid	$-262.57M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.01
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.10
Gross Margin	62.24%
Operating Margin	34.92%
EBIT Margin	34.92%
EBITDA Margin	--
Pre-Tax Profit Margin	35.09%
Profit Margin	27.86%
Free Cash Flow	$1.25B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.59
Receiveable Turnover	1.43
Days Sales in Receivables	62.80
Return on Equity	6.14%
Return on Tangible Equity	13.19%
Return on Assets	4.54%
Return on Investments	5.78%
Book Value Per Share	$44.76
Free Cash Flow per Share	$8.55
Operating Cash Flow per Share	$9.27

Data from Zacks Investment Research, Inc.